Publications

Complete Bibliography

Visit PubMed to see Dr. Steve Pergam's complete publications record.


Recent publications

Yoke LH, Lee JM, Krantz EM, Morris J, Marquis S, Bhattacharyya P, So L, Riedo FX, Simmons J, Khaki AR, Cheng GS, Greninger AL, Pergam SA, Waghmare A, Ogimi C, Liu C. Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center Open Forum Infect Dis. 2021 Apr 16;8(6):ofab193. doi: 10.1093/ofid/ofab193. eCollection 2021 Jun. PMID: 34183982

McEwen AE, Cohen S, Bryson-Cahn C, Liu C, Pergam SA, Lynch J, Schippers A, Strand K, Whimbey E, Mani NS, Zelikoff AJ, Makarewicz VA, Brown ER, Bakhash SAM, Baker NR, Castor J, Livingston RJ, Huang ML, Jerome KR, Greninger AL, Roychoudhury P. Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State Clin Infect Dis. 2021 Jun 24:ciab581. doi: 10.1093/cid/ciab581. Online ahead of print. PMID: 34166484

Lind ML, Maravilla Rosas M, McFarland L, Taylor L, Olson S, Pergam SA. Limits of the Glasgow Coma Scale When Assessing for Sepsis in Allogeneic Hematopoietic Cell Transplant Recipients Nurs Res. 2021 May 25. doi: 10.1097/NNR.0000000000000521. Online ahead of print. PMID: 34039938

Walti CS, Loes AN, Shuey K, Krantz EM, Boonyaratanakornkit J, Keane-Candib J, Loeffelholz T, Wolf CR, Taylor JJ, Gardner RA, Green DJ, Cowan AJ, Maloney DG, Turtle CJ, Pergam SA, Chu HY, Bloom JD, Hill JA. Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy medRxiv. 2021 May 11:2021.05.10.21256634. doi: 10.1101/2021.05.10.21256634. Preprint. PMID: 34013294

Pergam SA, Dadwal SS. Can a Simple Stool Swab Predict Bacteremia in High-Risk Hematopoietic Cell Transplant Recipients? Clin Infect Dis. 2021 May 7:ciab412. doi: 10.1093/cid/ciab412. Online ahead of print. PMID: 33961692

Friese CR, Choueiri TK, Duma N, Farmakiotis D, Grivas P, Rini BI, Shah DP, Thompson MA, Pergam SA, Mishra S, Warner JL. Care without a compass: including patients with cancer in COVID-19 studies Cancer Cell. 2021 Apr 15:S1535-6108(21)00214-2. doi: 10.1016/j.ccell.2021.04.006. Online ahead of print. PMID: 33894136

Woodfield MC, Pergam SA, Shah PD. Cocooning against COVID-19: The argument for vaccinating caregivers of patients with cancer Cancer. 2021 Apr 23:10.1002/cncr.33598. doi: 10.1002/cncr.33598. Online ahead of print. PMID: 33891713

Lind ML, Mooney SJ, Carone M, Althouse BM, Liu C, Evans LE, Patel K, Vo PT, Pergam SA, Phipps AI. Development and Validation of a Machine Learning Model to Estimate Bacterial Sepsis Among Immunocompromised Recipients of Stem Cell Transplant JAMA Netw Open. 2021 Apr 1;4(4):e214514. doi: 10.1001/jamanetworkopen.2021.4514. PMID: 33871619

Flores LE, Frontera WR, Andrasik MP, Del Rio C, Mondríguez-González A, Price SA, Krantz EM, Pergam SA, Silver JK. Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials JAMA Netw Open. 2021 Feb 1;4(2):e2037640. doi: 10.1001/jamanetworkopen.2020.37640. PMID: 33606033

Kates OS, Stohs EJ, Pergam SA, Rakita RM, Michaels MG, Wolfe CR, Danziger-Isakov L, Ison MG, Blumberg EA, Razonable RR, Gordon EJ, Diekema DS. The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy Am J Transplant. 2021 Jan 23. doi: 10.1111/ajt.16472. Online ahead of print. PMID: 33370501

Lindsay J, Othman J, Kerridge I, Fay K, Stevenson W, Arthur C, Chen SC, Kong DCM, Pergam SA, Liu C, Slavin MA, Greenwood M. Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearance Transpl Infect Dis. 2021 Jun;23(3):e13548. doi: 10.1111/tid.13548. Epub 2021 Jan 5. PMID: 33342000

Liu C, Lan K, Krantz EM, Kim HN, Zier J, Bryson-Cahn C, Chan JD, Jain R, Lynch JB, Pergam SA, Pottinger PS, Sweet A, Whimbey E, Bryan A. Improving Appropriate Diagnosis of Clostridioides difficile Infection Through an Enteric Pathogen Order Set With Computerized Clinical Decision Support: An Interrupted Time Series Analysis Open Forum Infect Dis. 2020 Aug 21;7(10):ofaa366. doi: 10.1093/ofid/ofaa366. eCollection 2020 Oct. PMID: 33094113

Ueda Oshima M, Sandmaier BM, Petersdorf E, Flowers ME, Hill GR, Lee SJ, Appelbaum FR, Carpenter PA, Baker KS, Connelly-Smith L, McCool A, Elgar S, Pergam SA, Liu C, Stewart FM, Mielcarek M. Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach Bone Marrow Transplant. 2021 Feb;56(2):305-313. doi: 10.1038/s41409-020-01068-x. Epub 2020 Sep 26. PMID: 32980860

 

Glasses

Selected Publications

Understanding risk factors and outcomes of cancer and transplant patients with community and hospital-acquired diarrheal pathogens

Boyle NM, Podczervinski S, Jordan K, Stednick Z, Butler-Wu SM, McMillen K, Pergam SA. Bacterial Foodborne Infections After Hematopoietic Cell Transplantation.  Biol Blood Marrow Transplant. 2014 2014 Nov;20(11):1856-61. PMCID: 4194273.

Boyle NM, Magaret A, Stednick Z, Morrison A, Butler-Wu S, Zerr D, Rogers K, Podczervinski S, Cheng A, Wald A, Pergam SA. Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrob Resist Infect Control. 2015 Oct 14;4:41. doi: 10.1186/s13756-015-0081-4. eCollection 2015. PMCID: PMC4606905.

Cohen S, Woodfield M, Boyle N, Stednick Z, Boeckh M, Pergam SA. Incidence and Outcomes of Bloodstream Infections among Hematopoietic Cell Transplant Recipients from Species Commonly Reported to be in Over-the-Counter Probiotic FormulationsTranspl Infect Dis. 2016 Aug 8. doi: 10.1111/tid.12587. [Epub ahead of print]. PMCID: PMC5160044.

Establishing risk of cytomegalovirus (CMV) in identifiable subsets of allogeneic transplant recipients

†Milano F, †Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, Chow V, Boeckh MJ, Delaney C. Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipientsBlood. 2011 Nov 17;118(20):5689-96. PMCID: 3217367. († = contributed equally)

Pergam SA, Xie H, Sandhu R, Pollack M, Smith J, Stevens-Ayers T, Ilieva V, Kimball LE, Huang ML, Hayes TS, Corey L, Boeckh MJ. Risk factors and efficiency of CMV transmission in seronegative hematopoietic stem cell recipientsBiol Blood Marrow Transplant. 2012 Sep;18(9):1391-400. PMCID: 3572857.

Understanding the risk of drug resistance and healthcare-associated infections in cancer patients undergoing chemotherapy and hematopoietic cell transplant (HCT)

Miles-Jay A, Butler-Wu S, Rowhani-Rahbar A, Pergam SA. Incidence rate of fluoroquinolone resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplant patients during an era of levofloxacin prophylaxis. Biol Blood Marrow Transplant. 2015 Mar;21(3):539-45. PMID: 25498393; PMCID: PMC4329069.

Miles-Jay A, Podczervinski S, Stednick ZJ, Pergam SA. Evaluation of routine pretransplanation screening for methicillin-resistant Staphylococcus aureus in hematopoietic cell transplant recipients. Am J Infect Control. 2015 Jan;43(1):89-91. PMCID: PMC4286793.

Addressing novel methods for the prevention of respiratory viruses in high-risk immunosuppressed hosts

Chu HY, Englund JA, Podczervinski S, Kuypers J, Campbell AP, Boeckh MJ, Pergam SA, Casper C. Nosocomial transmission of respiratory syncytial virus in an outpatient cancer centerBiol Blood Marrow Transplant. 2014 Jun;20(6):844-51. PMCID: 4036533.

Podczervinski S, Stednick Z, Helbert L, Davies J, Jagels B, Gooley T, Casper C, Pergam SA. Comparison of “Carrot-vs.-Stick” approaches to employee influenza vaccination in a large cancer center with high baseline compliance ratesAm J Infect Control. 2015 Mar 1;43(3):228-33. PMCID: PMC4372134.

Waghmare A, Pergam SA, Jerome KR, Englund JA, Boeckh M, Kuypers J. Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipientsBlood. 2015 Mar 12;125(11):1724-9. PMCID: PMC4357580.